The Cost of Lost Productivity Due to Premature Chagas Disease-Related Mortality: Lessons from Colombia (2010–2017)
Abstract
1. Introduction
2. Materials and Methods
2.1. Data Source
2.2. Estimation Methods
2.3. Sensitivity Analyses
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Olivera, M.J.; Porras, J.; Toquica, C.; Rodríguez, J. Barriers to diagnosis dccess for Chagas disease in Colombia. J. Parasitol. Res. 2018, 2018, 4940796. [Google Scholar] [CrossRef] [PubMed]
- Pinto Dias, J.C. Human Chagas disease and migration in the context of globalization: Some particular aspects. J. Trop. Med. 2013, 2013, 789758. [Google Scholar] [CrossRef]
- World Health Organization. Chagas disease in Latin America: An epidemiological update based on 2010 estimates. Wkly. Epidemiol. Rec. 2015, 90, 33–44. [Google Scholar]
- Olivera, M.J.; Buitrago, G. Economic costs of Chagas disease in Colombia in 2017: A social perspective. Int. J. Infect. Dis. 2020, 91, 196–201. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. First WHO Report on Neglected Tropical Diseases: Working to Overcome the Global Impact of Neglected Tropical Diseases. France, 2010. Available online: https://www.who.int/neglected_diseases/2010report/en/ (accessed on 6 March 2020).
- Gardner, J.W.; Sanborn, J.S. Years of potential life lost (YPLL)-What does it measure? Epidemiology 1990, 1, 322–329. [Google Scholar] [CrossRef]
- Darbà, J.; Marsà, A. The cost of lost productivity due to premature lung cancer-related mortality: Results from Spain over a 10-year period. BMC Cancer 2019, 19, 992. [Google Scholar] [CrossRef]
- Cucunubá, Z.M.; Okuwoga, O.; Basáñez, M.G.; Nouvellet, P. Increased mortality attributed to Chagas disease: A systematic review and meta-analysis. Parasites Vectors 2016, 9, 42. [Google Scholar] [CrossRef]
- Wise, R.P.; Livengood, J.R.; Berkelman, R.L.; Goodman, R.A. Methodological alternatives for measuring premature mortality. Am. J. Prev. Med. 1988, 4, 268–273. [Google Scholar] [CrossRef]
- Romeder, J.M.; McWhinnie, J.R. Potential years of life lost between ages 1 and 70: An indicator of premature mortality for health planning. Int. J. Epidemiol. 1977, 6, 143–151. [Google Scholar] [CrossRef]
- Zhong, Y.; Li, D. Potential years of life lost and work tenure lost when silicosis is compared with other pneumoconioses. Scand. J. Work Environ. Health 1995, 21, 91–94. [Google Scholar]
- Olivera, M.J.; Fory, J.A.; Porras, J.F.; Buitrago, G. Prevalence of Chagas disease in Colombia: A systematic review and meta-analysis. PLoS ONE 2019, 14, e0210156. [Google Scholar] [CrossRef] [PubMed]
- Banco de la República Colombia. Tasa Representativa del Mercado (TRM-Peso por dólar). Available online: https://www.banrep.gov.co/es/estadisticas/trm (accessed on 24 February 2020).
- Departamento Administrativo Nacional de Estadística. Mortalidad en Colombia, 2017. Available online: https://www.dane.gov.co/index.php/estadisticas-por-tema/demografia-y-poblacion/nacimientos-y-defunciones (accessed on 6 March 2020).
- Congreso de Colombia. Ley 100 de 1993. Por la Cual se Crea el Sistema de Seguridad Social Integral y se Dictan Otras Disposiciones. Available online: http://www.secretariasenado.gov.co/senado/basedoc/ley_0100_1993.html (accessed on 6 March 2020).
- Augustovski, F.; Alcaraz, A.; Caporale, J.; García Martí, S.; Pichon Riviere, A. Institutionalizing health technology assessment for priority setting and health policy in Latin America: From regional endeavors to national experiences. Expert Rev. Pharmacoecon. Outcomes Res. 2015, 15, 9–12. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Departamento Administrativo Nacional de Estadística. Encuesta Nacional de Calidad de vida 2018. 2019. Available online: https://www.dane.gov.co/index.php/estadisticas-por-tema/pobreza-y-condiciones-de-vida/calidad-de-vida-ecv (accessed on 6 March 2020).
- Olivera, M.J.; Cucunuba, Z.M.; Alvarez, C.A.; Nicholls, R.S. Safety profile of nifurtimox and treatment interruption for chronic Chagas disease in Colombian adults. Am. J. Trop. Med. Hyg. 2015, 93, 1224–1230. [Google Scholar] [CrossRef] [PubMed]
- Olivera, M.J.; Cucunuba, Z.M.; Valencia-Hernandez, C.A.; Herazo, R.; Agreda-Rudenko, D.; Florez, C.; Duque, S.; Nicholls, R.S. Risk factors for treatment interruption and severe adverse effects to benznidazole in adult patients with Chagas disease. PLoS ONE 2017, 12, e0185033. [Google Scholar] [CrossRef] [PubMed]
- Olivera, M.J.; Fory, J.A.; Olivera, A.J. Quality assessment of clinical practice guidelinesfor Chagas disease. Rev. Soc. Bras. Med. Trop. 2015, 48, 343–346. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Olivera, M.J.; Fory, J.A.; Olivera, A.J. Therapeutic drug monitoring of benznidazole and nifurtimox: A systematic review and quality assessment of published clinical practice guidelines. Rev. Soc. Bras. Med. Trop. 2017, 50, 748–755. [Google Scholar] [CrossRef]
- Basquiera, A.L.; Sembaj, A.; Aguerri, A.M.; Omelianiuk, M.; Guzmán, S.; Moreno Barral, J.; Caeiro, T.F.; Madoery, R.J.; Salomone, O.A. Risk progression to chronic Chagas cardiomyopathy: Influence of male sex and of parasitaemia detected by polymerase chain reaction. Heart 2003, 89, 1186–1190. [Google Scholar] [CrossRef]
- Sabino, E.C.; Ribeiro, A.L.; Salemi, V.M.C.; Di Lorenzo Oliveira, C.; Antunes, A.P.; Menezes, M.M.; Lanni, B.M.; Nastari, L.; Fernandes, F.; Patavino, G.M.; et al. Ten-year incidence of Chagas cardiomyopathy among asymptomatic trypanosoma cruzi-seropositive former blood donors. Circulation 2013, 127, 1105–1115. [Google Scholar] [CrossRef]
- Pelegrino, V.M.; Dantas, R.A.S.; Ciol, M.A.; Clark, A.M.; Rossi, L.A.; Simoes, M.V. Health-related quality of life in Brazilian outpatients with Chagas and non-Chagas cardiomyopathy. Heart Lung 2011, 40, e25–e31. [Google Scholar] [CrossRef]
- Oliveira, B.G.; Abreu, M.N.S.; Abreu, C.D.G.; da Costa Rocha, M.O.; Ribeiro, A.L. Health-related quality of life in patients with Chagas disease. Rev. Soc. Bras. Med. Trop. 2011, 44, 150–156. [Google Scholar] [CrossRef][Green Version]
- Olivera, M.J.; Chaverra, K.A. New diagnostic algorithm for Chagas disease: Impact on access to diagnosis and out-of-pocket expenditures in Colombia. Iran. J. Public Health 2019, 48, 1379–1381. [Google Scholar] [CrossRef] [PubMed]
- Drummond, M.; Sculpher, M.; Claxton, K.; Stoddart, G.; Torrance, G. Methods for the Economic Evaluation of Health Care Programmes, 4th ed.; Oxford University Press: Oxford, UK, 2015. [Google Scholar]
- Pike, J.; Grosse, S.D. Friction cost estimates of productivity costs in cost-of-illness studies in comparison with human capital estimates: A review. Appl. Health Econ. Health Policy 2018, 16, 765–778. [Google Scholar] [CrossRef] [PubMed]
Year | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | Total |
Number of Deaths | |||||||||
Males | 102 | 87 | 101 | 110 | 113 | 93 | 132 | 128 | 866 |
Females | 58 | 51 | 59 | 71 | 79 | 85 | 92 | 85 | 580 |
Total | 160 | 138 | 160 | 181 | 192 | 178 | 224 | 213 | 1446 |
Deaths at Working Age | |||||||||
Males | 84 | 69 | 88 | 95 | 93 | 83 | 117 | 112 | 741 |
Females | 52 | 45 | 51 | 64 | 72 | 76 | 84 | 76 | 520 |
Total | 136 | 114 | 139 | 159 | 165 | 159 | 201 | 188 | 1261 |
PYWL | |||||||||
Males | 3441 | 2822 | 3594 | 3900 | 3777 | 3348 | 4772 | 4583 | 30,237 |
Females | 1854 | 1593 | 1824 | 2263 | 2521 | 2682 | 2968 | 2679 | 18,384 |
Total | 5295 | 4415 | 5418 | 6163 | 6298 | 6030 | 7740 | 7262 | 48,621 |
Total Premature Mortality Cost | % of the Total | Premature Mortality Cost per Death | Premature Mortality Cost per PYWL | |
---|---|---|---|---|
Males | 17,301,237 | 58 | 23,348 | 572 |
Females | 12,382,676 | 42 | 23,813 | 674 |
Total | 29,683,913 | 100 | 23,540 | 611 |
Year | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
---|---|---|---|---|---|---|---|---|
Males | 1,862,873 | 1,541,799 | 2,008,175 | 2,198,782 | 2,206,153 | 1,986,068 | 2,793,321 | 2,704,067 |
Females | 1,174,136 | 1,023,484 | 1,183,187 | 1,509,232 | 1,736,916 | 1,846,584 | 2,040,400 | 1,868,737 |
Total | 3,037,009 | 2,565,283 | 3,191,362 | 3,708,014 | 3,943,069 | 3,832,652 | 4,833,722 | 4,572,803 |
Age Group/Year | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
---|---|---|---|---|---|---|---|---|
Adults | 22,597 | 68,203 | 46,165 | 47,106 | 96,491 | 72,932 | 170,012 | 98,320 |
Young | 3,014,412 | 2,497,081 | 3,145,197 | 3,660,908 | 3,846,578 | 3,759,719 | 4,663,710 | 4,474,483 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Olivera, M.J.; Palencia-Sánchez, F.; Riaño-Casallas, M. The Cost of Lost Productivity Due to Premature Chagas Disease-Related Mortality: Lessons from Colombia (2010–2017). Trop. Med. Infect. Dis. 2021, 6, 17. https://doi.org/10.3390/tropicalmed6010017
Olivera MJ, Palencia-Sánchez F, Riaño-Casallas M. The Cost of Lost Productivity Due to Premature Chagas Disease-Related Mortality: Lessons from Colombia (2010–2017). Tropical Medicine and Infectious Disease. 2021; 6(1):17. https://doi.org/10.3390/tropicalmed6010017
Chicago/Turabian StyleOlivera, Mario J., Francisco Palencia-Sánchez, and Martha Riaño-Casallas. 2021. "The Cost of Lost Productivity Due to Premature Chagas Disease-Related Mortality: Lessons from Colombia (2010–2017)" Tropical Medicine and Infectious Disease 6, no. 1: 17. https://doi.org/10.3390/tropicalmed6010017
APA StyleOlivera, M. J., Palencia-Sánchez, F., & Riaño-Casallas, M. (2021). The Cost of Lost Productivity Due to Premature Chagas Disease-Related Mortality: Lessons from Colombia (2010–2017). Tropical Medicine and Infectious Disease, 6(1), 17. https://doi.org/10.3390/tropicalmed6010017